APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis (TB) Detection

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.

Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.

Selected research

Market Analysis & Forecast

Global Tuberculosis (TB) Detection Market Analysis and Forecast 2026-2032

28 December 2025194 pages

Choose your research edition.

Industry ResearchTuberculosis (TB) Detection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis (TB) Detection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Tuberculosis (TB) Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis (TB) Detection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis (TB) Detection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.

Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.

In Southeast Asia, Tuberculosis (TB) Detection key players include Danaher, Roche, Thermal Fisher, Abbott, etc.

Read the full market overview

Indonesia is the largest market, with a share over 20%, followed by Philippines, and Myanmar, both have a share about 30 percent.

In terms of product, Bacterial Culture Test is the largest segment, with a share about 50%. And in terms of application, the largest application is Hospital, followed by Clinic, Research Institution, etc.

Report Includes

This report presents an overview of global market for Tuberculosis (TB) Detection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tuberculosis (TB) Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for Tuberculosis (TB) Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis (TB) Detection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tuberculosis (TB) Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Tuberculosis (TB) Detection revenue, projected growth trends, production technology, application and end-user industry.

Tuberculosis (TB) Detection Segment by Company

Danaher

Roche

Thermal Fisher

Abbott

Oxford Immunotec International

Qiagen

Hologic

Hain Lifescience

Epistem

Creative Diagnostics

Tuberculosis (TB) Detection Segment by Type

Bacterial Culture Test

Tuberculin Test

Rapid Molecular Diagnosis

Other

Tuberculosis (TB) Detection Segment by Application

Hospital

Clinic

Research Institution

Other

Tuberculosis (TB) Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Tuberculosis (TB) Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Tuberculosis (TB) Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Detection revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tuberculosis (TB) Detection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bacterial Culture Test Major Player Table 3. Tuberculin Test Major Player Table 4. Rapid Molecular Diagnosis Major Player Table 5. Other Major Player Table 6. Global Tuberculosis (TB) Detection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Research Institution Major Player Table 10. Other Major Player Table 11. Tuberculosis (TB) Detection Industry Trends Table 12. Tuberculosis (TB) Detection Industry Drivers Table 13. Tuberculosis (TB) Detection Industry Opportunities and Challenges Table 14. Tuberculosis (TB) Detection Industry Restraints Table 15. Global Tuberculosis (TB) Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Tuberculosis (TB) Detection Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Tuberculosis (TB) Detection Market Share by Region (2021-2026) Table 18. Global Tuberculosis (TB) Detection Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Tuberculosis (TB) Detection Market Share by Region (2027-2032) Table 20. Global Tuberculosis (TB) Detection Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Tuberculosis (TB) Detection Revenue Market Share by Players (2021-2026) Table 22. Global Tuberculosis (TB) Detection Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Tuberculosis (TB) Detection Key Players Headquarters & Area Served Table 24. Global Tuberculosis (TB) Detection Players, Product Type & Application Table 25. Global Tuberculosis (TB) Detection Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Tuberculosis (TB) Detection by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Tuberculosis (TB) Detection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Tuberculosis (TB) Detection Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Tuberculosis (TB) Detection Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Tuberculosis (TB) Detection Revenue Market Share by Type (2021-2026) Table 32. Global Tuberculosis (TB) Detection Revenue Market Share by Type (2027-2032) Table 33. Global Tuberculosis (TB) Detection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Tuberculosis (TB) Detection Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Tuberculosis (TB) Detection Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Tuberculosis (TB) Detection Revenue Market Share by Application (2021-2026) Table 37. Global Tuberculosis (TB) Detection Revenue Market Share by Application (2027-2032) Table 38. Danaher Company Information Table 39. Danaher Business Overview Table 40. Danaher Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Danaher Tuberculosis (TB) Detection Product Portfolio Table 42. Danaher Recent Development Table 43. Roche Company Information Table 44. Roche Business Overview Table 45. Roche Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Roche Tuberculosis (TB) Detection Product Portfolio Table 47. Roche Recent Development Table 48. Thermal Fisher Company Information Table 49. Thermal Fisher Business Overview Table 50. Thermal Fisher Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Thermal Fisher Tuberculosis (TB) Detection Product Portfolio Table 52. Thermal Fisher Recent Development Table 53. Abbott Company Information Table 54. Abbott Business Overview Table 55. Abbott Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Abbott Tuberculosis (TB) Detection Product Portfolio Table 57. Abbott Recent Development Table 58. Oxford Immunotec International Company Information Table 59. Oxford Immunotec International Business Overview Table 60. Oxford Immunotec International Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Oxford Immunotec International Tuberculosis (TB) Detection Product Portfolio Table 62. Oxford Immunotec International Recent Development Table 63. Qiagen Company Information Table 64. Qiagen Business Overview Table 65. Qiagen Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Qiagen Tuberculosis (TB) Detection Product Portfolio Table 67. Qiagen Recent Development Table 68. Hologic Company Information Table 69. Hologic Business Overview Table 70. Hologic Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Hologic Tuberculosis (TB) Detection Product Portfolio Table 72. Hologic Recent Development Table 73. Hain Lifescience Company Information Table 74. Hain Lifescience Business Overview Table 75. Hain Lifescience Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Hain Lifescience Tuberculosis (TB) Detection Product Portfolio Table 77. Hain Lifescience Recent Development Table 78. Epistem Company Information Table 79. Epistem Business Overview Table 80. Epistem Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Epistem Tuberculosis (TB) Detection Product Portfolio Table 82. Epistem Recent Development Table 83. Creative Diagnostics Company Information Table 84. Creative Diagnostics Business Overview Table 85. Creative Diagnostics Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Creative Diagnostics Tuberculosis (TB) Detection Product Portfolio Table 87. Creative Diagnostics Recent Development Table 88. North America Tuberculosis (TB) Detection Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Tuberculosis (TB) Detection Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Tuberculosis (TB) Detection Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Tuberculosis (TB) Detection Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Tuberculosis (TB) Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Tuberculosis (TB) Detection Revenue by Country (2021-2026) & (US$ Million) Table 94. North America Tuberculosis (TB) Detection Revenue by Country (US$ Million) & (2027-2032) Table 95. Europe Tuberculosis (TB) Detection Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Tuberculosis (TB) Detection Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Tuberculosis (TB) Detection Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Tuberculosis (TB) Detection Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Tuberculosis (TB) Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Tuberculosis (TB) Detection Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Tuberculosis (TB) Detection Revenue by Country (US$ Million) & (2027-2032) Table 102. China Tuberculosis (TB) Detection Revenue by Type (2021-2026) & (US$ Million) Table 103. China Tuberculosis (TB) Detection Revenue by Type (2027-2032) & (US$ Million) Table 104. China Tuberculosis (TB) Detection Revenue by Application (2021-2026) & (US$ Million) Table 105. China Tuberculosis (TB) Detection Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Tuberculosis (TB) Detection Revenue by Type (2021-2026) & (US$ Million) Table 107. Asia Tuberculosis (TB) Detection Revenue by Type (2027-2032) & (US$ Million) Table 108. Asia Tuberculosis (TB) Detection Revenue by Application (2021-2026) & (US$ Million) Table 109. Asia Tuberculosis (TB) Detection Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Tuberculosis (TB) Detection Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Asia Tuberculosis (TB) Detection Revenue by Region (US$ Million) & (2021-2026) Table 112. Asia Tuberculosis (TB) Detection Revenue by Region (US$ Million) & (2027-2032) Table 113. SAMEA Tuberculosis (TB) Detection Revenue by Type (2021-2026) & (US$ Million) Table 114. SAMEA Tuberculosis (TB) Detection Revenue by Type (2027-2032) & (US$ Million) Table 115. SAMEA Tuberculosis (TB) Detection Revenue by Application (2021-2026) & (US$ Million) Table 116. SAMEA Tuberculosis (TB) Detection Revenue by Application (2027-2032) & (US$ Million) Table 117. SAMEA Tuberculosis (TB) Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. SAMEA Tuberculosis (TB) Detection Revenue by Country (2021-2026) & (US$ Million) Table 119. SAMEA Tuberculosis (TB) Detection Revenue by Country (US$ Million) & (2027-2032) Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Tuberculosis (TB) Detection Image Figure 2. Global Tuberculosis (TB) Detection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis (TB) Detection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bacterial Culture Test Image Figure 5. Tuberculin Test Image Figure 6. Rapid Molecular Diagnosis Image Figure 7. Other Image Figure 8. Global Tuberculosis (TB) Detection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Tuberculosis (TB) Detection Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Research Institution Image Figure 13. Other Image Figure 14. Global Tuberculosis (TB) Detection Market Size (US$ Million) & (2021-2032) Figure 15. Global Tuberculosis (TB) Detection Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Tuberculosis (TB) Detection Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Tuberculosis (TB) Detection Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Tuberculosis (TB) Detection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Tuberculosis (TB) Detection Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Tuberculosis (TB) Detection Revenue Market Share by Type (2021-2032) Figure 22. Global Tuberculosis (TB) Detection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Tuberculosis (TB) Detection Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Tuberculosis (TB) Detection Revenue Market Share by Application (2021-2032) Figure 25. North America Tuberculosis (TB) Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Tuberculosis (TB) Detection Revenue Share by Type (2021-2032) Figure 27. North America Tuberculosis (TB) Detection Revenue Share by Application (2021-2032) Figure 28. North America Tuberculosis (TB) Detection Revenue Share by Country (2021-2032) Figure 29. United States Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Tuberculosis (TB) Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Tuberculosis (TB) Detection Revenue Share by Type (2021-2032) Figure 34. Europe Tuberculosis (TB) Detection Revenue Share by Application (2021-2032) Figure 35. Europe Tuberculosis (TB) Detection Revenue Share by Country (2021-2032) Figure 36. Germany Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Tuberculosis (TB) Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Tuberculosis (TB) Detection Revenue Share by Type (2021-2032) Figure 46. China Tuberculosis (TB) Detection Revenue Share by Application (2021-2032) Figure 47. Asia Tuberculosis (TB) Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Tuberculosis (TB) Detection Revenue Share by Type (2021-2032) Figure 49. Asia Tuberculosis (TB) Detection Revenue Share by Application (2021-2032) Figure 50. Asia Tuberculosis (TB) Detection Revenue Share by Region (2021-2032) Figure 51. Japan Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Tuberculosis (TB) Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Tuberculosis (TB) Detection Revenue Share by Type (2021-2032) Figure 59. SAMEA Tuberculosis (TB) Detection Revenue Share by Application (2021-2032) Figure 60. SAMEA Tuberculosis (TB) Detection Revenue Share by Country (2021-2032) Figure 61. Brazil Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Tuberculosis (TB) Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Bacterial Culture Test
  • Tuberculin Test
  • Rapid Molecular Diagnosis
  • Other
Applications
  • Hospital
  • Clinic
  • Research Institution
  • Other
Companies covered
  • Danaher
  • Roche
  • Thermal Fisher
  • Abbott
  • Oxford Immunotec International
  • Qiagen
  • Hologic
  • Hain Lifescience
  • Epistem
  • Creative Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tuberculosis (TB) Detection Market by Type
  3. 1.2.1 Global Tuberculosis (TB) Detection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bacterial Culture Test
  5. 1.2.3 Tuberculin Test
  6. 1.2.4 Rapid Molecular Diagnosis
  7. 1.2.5 Other
  8. 1.3 Tuberculosis (TB) Detection Market by Application
  9. 1.3.1 Global Tuberculosis (TB) Detection Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Research Institution
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Tuberculosis (TB) Detection Market Dynamics
  1. 2.1 Tuberculosis (TB) Detection Industry Trends
  2. 2.2 Tuberculosis (TB) Detection Industry Drivers
  3. 2.3 Tuberculosis (TB) Detection Industry Opportunities and Challenges
  4. 2.4 Tuberculosis (TB) Detection Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Tuberculosis (TB) Detection Market Perspective (2021-2032)
  2. 3.2 Global Tuberculosis (TB) Detection Growth Trends by Region
  3. 3.2.1 Global Tuberculosis (TB) Detection Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tuberculosis (TB) Detection Market Size by Region (2021-2026)
  5. 3.2.3 Global Tuberculosis (TB) Detection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Tuberculosis (TB) Detection Revenue by Players
  2. 4.1.1 Global Tuberculosis (TB) Detection Revenue by Players (2021-2026)
  3. 4.1.2 Global Tuberculosis (TB) Detection Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Tuberculosis (TB) Detection Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tuberculosis (TB) Detection Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Tuberculosis (TB) Detection Key Players Headquarters & Area Served
  7. 4.4 Global Tuberculosis (TB) Detection Players, Product Type & Application
  8. 4.5 Global Tuberculosis (TB) Detection Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Tuberculosis (TB) Detection Market CR5 and HHI
  11. 4.6.3 2025 Tuberculosis (TB) Detection Tier 1, Tier 2, and Tier 3
5 Tuberculosis (TB) Detection Market Size by Type
  1. 5.1 Global Tuberculosis (TB) Detection Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Tuberculosis (TB) Detection Revenue by Type (2021-2032)
  3. 5.3 Global Tuberculosis (TB) Detection Revenue Market Share by Type (2021-2032)
6 Tuberculosis (TB) Detection Market Size by Application
  1. 6.1 Global Tuberculosis (TB) Detection Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Tuberculosis (TB) Detection Revenue by Application (2021-2032)
  3. 6.3 Global Tuberculosis (TB) Detection Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Danaher
  2. 7.1.1 Danaher Company Information
  3. 7.1.2 Danaher Business Overview
  4. 7.1.3 Danaher Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Danaher Tuberculosis (TB) Detection Product Portfolio
  6. 7.1.5 Danaher Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Tuberculosis (TB) Detection Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Thermal Fisher
  14. 7.3.1 Thermal Fisher Company Information
  15. 7.3.2 Thermal Fisher Business Overview
  16. 7.3.3 Thermal Fisher Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermal Fisher Tuberculosis (TB) Detection Product Portfolio
  18. 7.3.5 Thermal Fisher Recent Developments
  19. 7.4 Abbott
  20. 7.4.1 Abbott Company Information
  21. 7.4.2 Abbott Business Overview
  22. 7.4.3 Abbott Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Tuberculosis (TB) Detection Product Portfolio
  24. 7.4.5 Abbott Recent Developments
  25. 7.5 Oxford Immunotec International
  26. 7.5.1 Oxford Immunotec International Company Information
  27. 7.5.2 Oxford Immunotec International Business Overview
  28. 7.5.3 Oxford Immunotec International Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Oxford Immunotec International Tuberculosis (TB) Detection Product Portfolio
  30. 7.5.5 Oxford Immunotec International Recent Developments
  31. 7.6 Qiagen
  32. 7.6.1 Qiagen Company Information
  33. 7.6.2 Qiagen Business Overview
  34. 7.6.3 Qiagen Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Qiagen Tuberculosis (TB) Detection Product Portfolio
  36. 7.6.5 Qiagen Recent Developments
  37. 7.7 Hologic
  38. 7.7.1 Hologic Company Information
  39. 7.7.2 Hologic Business Overview
  40. 7.7.3 Hologic Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Hologic Tuberculosis (TB) Detection Product Portfolio
  42. 7.7.5 Hologic Recent Developments
  43. 7.8 Hain Lifescience
  44. 7.8.1 Hain Lifescience Company Information
  45. 7.8.2 Hain Lifescience Business Overview
  46. 7.8.3 Hain Lifescience Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hain Lifescience Tuberculosis (TB) Detection Product Portfolio
  48. 7.8.5 Hain Lifescience Recent Developments
  49. 7.9 Epistem
  50. 7.9.1 Epistem Company Information
  51. 7.9.2 Epistem Business Overview
  52. 7.9.3 Epistem Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Epistem Tuberculosis (TB) Detection Product Portfolio
  54. 7.9.5 Epistem Recent Developments
  55. 7.10 Creative Diagnostics
  56. 7.10.1 Creative Diagnostics Company Information
  57. 7.10.2 Creative Diagnostics Business Overview
  58. 7.10.3 Creative Diagnostics Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Diagnostics Tuberculosis (TB) Detection Product Portfolio
  60. 7.10.5 Creative Diagnostics Recent Developments
8 North America
  1. 8.1 North America Tuberculosis (TB) Detection Revenue (2021-2032)
  2. 8.2 North America Tuberculosis (TB) Detection Revenue by Type (2021-2032)
  3. 8.2.1 North America Tuberculosis (TB) Detection Revenue by Type (2021-2026)
  4. 8.2.2 North America Tuberculosis (TB) Detection Revenue by Type (2027-2032)
  5. 8.3 North America Tuberculosis (TB) Detection Revenue Share by Type (2021-2032)
  6. 8.4 North America Tuberculosis (TB) Detection Revenue by Application (2021-2032)
  7. 8.4.1 North America Tuberculosis (TB) Detection Revenue by Application (2021-2026)
  8. 8.4.2 North America Tuberculosis (TB) Detection Revenue by Application (2027-2032)
  9. 8.5 North America Tuberculosis (TB) Detection Revenue Share by Application (2021-2032)
  10. 8.6 North America Tuberculosis (TB) Detection Revenue by Country
  11. 8.6.1 North America Tuberculosis (TB) Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Tuberculosis (TB) Detection Revenue by Country (2021-2026)
  13. 8.6.3 North America Tuberculosis (TB) Detection Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Tuberculosis (TB) Detection Revenue (2021-2032)
  2. 9.2 Europe Tuberculosis (TB) Detection Revenue by Type (2021-2032)
  3. 9.2.1 Europe Tuberculosis (TB) Detection Revenue by Type (2021-2026)
  4. 9.2.2 Europe Tuberculosis (TB) Detection Revenue by Type (2027-2032)
  5. 9.3 Europe Tuberculosis (TB) Detection Revenue Share by Type (2021-2032)
  6. 9.4 Europe Tuberculosis (TB) Detection Revenue by Application (2021-2032)
  7. 9.4.1 Europe Tuberculosis (TB) Detection Revenue by Application (2021-2026)
  8. 9.4.2 Europe Tuberculosis (TB) Detection Revenue by Application (2027-2032)
  9. 9.5 Europe Tuberculosis (TB) Detection Revenue Share by Application (2021-2032)
  10. 9.6 Europe Tuberculosis (TB) Detection Revenue by Country
  11. 9.6.1 Europe Tuberculosis (TB) Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Tuberculosis (TB) Detection Revenue by Country (2021-2026)
  13. 9.6.3 Europe Tuberculosis (TB) Detection Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Tuberculosis (TB) Detection Revenue (2021-2032)
  2. 10.2 China Tuberculosis (TB) Detection Revenue by Type (2021-2032)
  3. 10.2.1 China Tuberculosis (TB) Detection Revenue by Type (2021-2026)
  4. 10.2.2 China Tuberculosis (TB) Detection Revenue by Type (2027-2032)
  5. 10.3 China Tuberculosis (TB) Detection Revenue Share by Type (2021-2032)
  6. 10.4 China Tuberculosis (TB) Detection Revenue by Application (2021-2032)
  7. 10.4.1 China Tuberculosis (TB) Detection Revenue by Application (2021-2026)
  8. 10.4.2 China Tuberculosis (TB) Detection Revenue by Application (2027-2032)
  9. 10.5 China Tuberculosis (TB) Detection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tuberculosis (TB) Detection Revenue (2021-2032)
  2. 11.2 Asia Tuberculosis (TB) Detection Revenue by Type (2021-2032)
  3. 11.2.1 Asia Tuberculosis (TB) Detection Revenue by Type (2021-2026)
  4. 11.2.2 Asia Tuberculosis (TB) Detection Revenue by Type (2027-2032)
  5. 11.3 Asia Tuberculosis (TB) Detection Revenue Share by Type (2021-2032)
  6. 11.4 Asia Tuberculosis (TB) Detection Revenue by Application (2021-2032)
  7. 11.4.1 Asia Tuberculosis (TB) Detection Revenue by Application (2021-2026)
  8. 11.4.2 Asia Tuberculosis (TB) Detection Revenue by Application (2027-2032)
  9. 11.5 Asia Tuberculosis (TB) Detection Revenue Share by Application (2021-2032)
  10. 11.6 Asia Tuberculosis (TB) Detection Revenue by Country
  11. 11.6.1 Asia Tuberculosis (TB) Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Tuberculosis (TB) Detection Revenue by Country (2021-2026)
  13. 11.6.3 Asia Tuberculosis (TB) Detection Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tuberculosis (TB) Detection Revenue (2021-2032)
  2. 12.2 SAMEA Tuberculosis (TB) Detection Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Tuberculosis (TB) Detection Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Tuberculosis (TB) Detection Revenue by Type (2027-2032)
  5. 12.3 SAMEA Tuberculosis (TB) Detection Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Tuberculosis (TB) Detection Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Tuberculosis (TB) Detection Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Tuberculosis (TB) Detection Revenue by Application (2027-2032)
  9. 12.5 SAMEA Tuberculosis (TB) Detection Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Tuberculosis (TB) Detection Revenue by Country
  11. 12.6.1 SAMEA Tuberculosis (TB) Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Tuberculosis (TB) Detection Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Tuberculosis (TB) Detection Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst